PCK2 and type 2 diabetes mellitus: It can also significantly down-regulate the gene expression of key gluconeogenesis enzymes PEPCK and G6PC in T2DM mice, inhibit the enzyme activities of PEPCK and G-6-Pase to weaken gluconeogenesis, and finally, improve glucose homeostasis in vivo.